These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 15973304

  • 1. Statistical process control and calcineurin inhibitor management.
    Dunn SP.
    J Pediatr; 2005 Jun; 146(6):720-1. PubMed ID: 15973304
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Calcineurin inhibitors in heart transplantation.
    Crespo-Leiro MG.
    Transplant Proc; 2005 Nov; 37(9):4018-20. PubMed ID: 16386614
    [Abstract] [Full Text] [Related]

  • 6. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
    Ventura E, Bonardet A, Pageaux GP, Mourad G, Cristol JP.
    Transplant Proc; 2009 Mar; 41(2):707-9. PubMed ID: 19328963
    [Abstract] [Full Text] [Related]

  • 7. [The anti-calcineurins (cyclosporin and tacrolimus)].
    Raymond S, Limat S, Woronoff-Lemsi MC.
    Soins; 2007 Jun; (716):61-3. PubMed ID: 17718044
    [No Abstract] [Full Text] [Related]

  • 8. Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients.
    Melter M, Rodeck B, Kardorff R, Hoyer PF, Maibücher A, Brodehl J.
    Transplant Proc; 1996 Aug; 28(4):2276-8. PubMed ID: 8769224
    [No Abstract] [Full Text] [Related]

  • 9. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B.
    Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Impaired erythropoietin production in liver transplant recipients: the role of calcineurin inhibitors.
    Bardet V, Junior AP, Coste J, Lecoq-Lafon C, Chouzenoux S, Bernard D, Soubrane O, Lacombe C, Calmus Y, Conti F.
    Liver Transpl; 2006 Nov; 12(11):1649-54. PubMed ID: 17058250
    [Abstract] [Full Text] [Related]

  • 13. [Controversies about the use of calcineurin inhibitors in pediatric patients].
    Dello Strologo L.
    G Ital Nefrol; 2008 Nov; 25(3):317-24. PubMed ID: 18473303
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tacrolimus and ciclosporin microemulsion in renal transplantation.
    Schieppati A, Perico N, Remuzzi G.
    Lancet; 2002 Sep 07; 360(9335):799-800, author reply 800-1. PubMed ID: 12241845
    [No Abstract] [Full Text] [Related]

  • 16. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W, Albani J, Englert C, Spehr A, Grabhorn E, Kemper MJ, Burdelski M, Ganschow R.
    Pediatr Transplant; 2006 Dec 07; 10(8):938-42. PubMed ID: 17096762
    [Abstract] [Full Text] [Related]

  • 17. [Advances in immunossuppression in liver transplantation].
    Olivera-Martínez MA.
    Rev Invest Clin; 2005 Dec 07; 57(2):237-43. PubMed ID: 16524064
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.